Seeking Alpha

Argus upgrades Forest Labs (FRX) to buy, citing a strong product pipeline that includes...

Argus upgrades Forest Labs (FRX) to buy, citing a strong product pipeline that includes potential blockbuster Daliresp for treating pulmonary disease, hypertension drug Bystolic, plus its Teflaro antibiotic. Shares +1.2% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs